CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Return
20.55%
This Quarter Return
+9.08%
1 Year Return
+20.55%
3 Year Return
+73.62%
5 Year Return
+131.25%
10 Year Return
–
AUM
$7.06B
AUM Growth
+$739M
(+12%)
Cap. Flow
+$194M
Cap. Flow
% of AUM
2.75%
Top 10 Holdings %
Top 10 Hldgs %
64.54%
Holding
1,102
New
171
Increased
503
Reduced
296
Closed
86
Top Buys
| 1 |
Apple
AAPL
|
$56M |
| 2 |
iShares Gold Trust
IAU
|
$35.5M |
| 3 |
Palantir
PLTR
|
$29.1M |
| 4 |
Vanguard Small-Cap Value ETF
VBR
|
$25.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
$21M |
Top Sells
| 1 |
ARK Innovation ETF
ARKK
|
$76.4M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
$20.3M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$17M |
| 4 |
Invesco Preferred ETF
PGX
|
$15.8M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$15.3M |
Sector Composition
| 1 | Technology | 40.17% |
| 2 | Consumer Discretionary | 6.8% |
| 3 | Healthcare | 3.61% |
| 4 | Financials | 3.09% |
| 5 | Communication Services | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
901
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $227K | ﹤0.01% |
+2,421
| New | +$227K |
|
|
PSXP
902
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $227K | ﹤0.01% |
+5,750
| New | +$227K |
|
903
Franco-Nevada
FNV
$37.3B
| $226K | ﹤0.01% |
+1,557
| New | +$226K |
|
904
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.3B
| $226K | ﹤0.01% |
+3,726
| New | +$226K |
|
905
Choice Hotels
CHH
$5.41B
| $224K | ﹤0.01% |
1,880
-336
| -15% | -$40K |
|
906
Nasdaq
NDAQ
$53.6B
| $224K | ﹤0.01% |
3,813
-1,365
| -26% | -$80.2K |
|
907
Sunrun
RUN
$4.19B
| $224K | ﹤0.01% |
+4,009
| New | +$224K |
|
908
Qiagen
QGEN
$10.3B
| $220K | ﹤0.01% |
+4,295
| New | +$220K |
|
909
Teva Pharmaceuticals
TEVA
$21.7B
| $220K | ﹤0.01% |
22,206
-258
| -1% | -$2.56K |
|
910
Public Service Enterprise Group
PEG
$40.5B
| $219K | ﹤0.01% |
+3,660
| New | +$219K |
|
911
PJT Partners
PJT
$4.38B
| $219K | ﹤0.01% |
3,068
| – | – |
|
912
Vertex
VERX
$3.83B
| $219K | ﹤0.01% |
+9,998
| New | +$219K |
|
913
ENI
E
$51.3B
| $218K | ﹤0.01% |
8,936
+250
| +3% | +$6.1K |
|
914
Eversource Energy
ES
$23.6B
| $218K | ﹤0.01% |
2,716
-389
| -13% | -$31.2K |
|
915
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$15.7B
| $218K | ﹤0.01% |
4,157
-147
| -3% | -$7.71K |
|
916
Brown-Forman Class A
BF.A
$13.8B
| $217K | ﹤0.01% |
+3,068
| New | +$217K |
|
917
Ingersoll Rand
IR
$32.2B
| $217K | ﹤0.01% |
4,459
+171
| +4% | +$8.32K |
|
|
JMIA
918
Jumia Technologies
JMIA
$1.09B
| $217K | ﹤0.01% |
+7,171
| New | +$217K |
|
919
Lloyds Banking Group
LYG
$64.5B
| $217K | ﹤0.01% |
85,161
+9,150
| +12% | +$23.3K |
|
920
Mohawk Industries
MHK
$8.65B
| $217K | ﹤0.01% |
1,132
-6
| -0.5% | -$1.15K |
|
921
Principal Financial Group
PFG
$17.8B
| $217K | ﹤0.01% |
+3,438
| New | +$217K |
|
922
Darden Restaurants
DRI
$24.5B
| $216K | ﹤0.01% |
+1,479
| New | +$216K |
|
923
Dorman Products
DORM
$5B
| $215K | ﹤0.01% |
2,072
-346
| -14% | -$35.9K |
|
924
iShares Biotechnology ETF
IBB
$5.8B
| $214K | ﹤0.01% |
1,309
-1,149
| -47% | -$188K |
|
925
Kulicke & Soffa
KLIC
$1.99B
| $214K | ﹤0.01% |
+3,491
| New | +$214K |
|